NCT06978738 UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases Status NOT_YET_RECRUITING Phase PHASE1
NCT02725476 Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD) Status COMPLETED Phase PHASE2